CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čes, .slov. Derm., 70, 2004, No. 6, p. 200-204
 
Our Clinical Experience with the Use of Photodynamic Therapy in Patients with the Basal Cell Carcinoma and Morbus Bowen (Comparison of Efficacy of Two Photosensitizers) 
Vaicová M., Ettler K. 

Klinika nemocí kožních a pohlavních LF UK, Hradec Královépřednosta doc. MUDr. Karel Ettler, CSc.
 


Summary:

       The group of 18 patients (11 males and 7 females) treated by photodynamic therapy (PDT) at the Department of Dermatology of the Faculty Hospital in Hradec Králové during the period 1999-2003 was followed. Photosensitizers meso-tetra-para-sulphophenyl-porphin (TPPS4) and -aminolevulic acid (ALA) followed by irradiation by a source of visible light with the wave length of 600-800 nm in doses of 120-200 J/cm2 were used. In 16 patients the solitary or multiple basal cell carcinoma were histologically confirmed, one patient had morbus Bowen and one had both morbus Bowen and basal cell carcinoma. PDT with TPPS4 was given to 7 patients, 10 patients received ALA and 1 patient was treated with TPPS4 and also ALA later on. Evaluation after 6 months showed 62.5% healed lesions after TPPS4 use and only 50% after local ALA application. Nevertheless, the PDT seems to be a perspective method in the treatment of localized skin tumors and superficial inflammatory skin diseases. However, its wider use is conditioned by the registration of photosensitizing substances in the Czech Republic.

        Key words: photodynamic therapy - TPPS4 - ALA
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER